Furthermore, García-Tobilla et al. 20 showed reduced gene expression of SFRP4 in prostate cancer cell lines (LNCaP, PC3, DU145 and 22Rv1) compared with control cells (PREC). Here, SFRP4 is linked to prostate carcinoma.